Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Min-Jee Kim

Showing results (171-180 of 173) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 173 results.
Research (Washington, D.C.)|February 12, 2026
Tumor Exosomal L1 Cell Adhesion Molecule Promotes Brain Metastasis of Lung CancerDong Ha Kim, Chae Won Lee, Yun Jung Choi, et al.
Neuro-Oncology|July 8, 2024
Safety and efficacy of selumetinib in pediatric and adult patients with neurofibromatosis type 1 and plexiform neurofibromaHyery Kim, Hee Mang Yoon, Eun Key Kim, et al.
Translational Lung Cancer Research|February 9, 2026
Clinical implications of plasma EGFR T790M and ctDNA shedding across metastatic sites in plasma- or tissue-confirmed EGFR-mutant non-small cell lung cancer treated with lazertinib: a prospective multicenter cohort studyMin Jee Kim, Junghee Jung, Wonjun Ji, et al.
Pageof 18

Showing results (171-180 of 173) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 173 results.
Research (Washington, D.C.)|February 12, 2026
Tumor Exosomal L1 Cell Adhesion Molecule Promotes Brain Metastasis of Lung CancerDong Ha Kim, Chae Won Lee, Yun Jung Choi, et al.
Neuro-Oncology|July 8, 2024
Safety and efficacy of selumetinib in pediatric and adult patients with neurofibromatosis type 1 and plexiform neurofibromaHyery Kim, Hee Mang Yoon, Eun Key Kim, et al.
Translational Lung Cancer Research|February 9, 2026
Clinical implications of plasma EGFR T790M and ctDNA shedding across metastatic sites in plasma- or tissue-confirmed EGFR-mutant non-small cell lung cancer treated with lazertinib: a prospective multicenter cohort studyMin Jee Kim, Junghee Jung, Wonjun Ji, et al.
Pageof 18